MDM2 amplification and loss of heterozygosity at Rb and p53 genes: No simultaneous alterations in the oncogenesis of liposarcomas

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 10, 1998, Pages 532-540

  Schneider Stock, R ^a   Walter, H ^a   Radig, K ^a   Rys, J ^b   Bosse, A ^c   Kuhnen, C ^d   Hoang Vu, C ^e   Roessner, A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c Katharinenhospital ^*  (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Liposarcoma; MDM2 amplification; p53 LOH; p53 mutation; Rb LOH

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOSARCOMA; MALE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; FEMALE; GENE AMPLIFICATION; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; LIPOSARCOMA; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2;

EID: 0031732740     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050211     Document Type: Article

References (44)

1. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR (1991) p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res 51:6393-6396
2. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991) Analysis of the variable number of tandem repeats locus D1S80 by the polymerase chain reaction followed by high resolution polyacrylamide gel electrophoresis. Am J Hum Genet 48:137-144
3. Bueso-Ramos C, Yang Y, Manshhouri T, Feltz L, Ayala A, Glassman AB, Albitar M (1995) Molecular abnormalities of MDM2 in human sarcomas. Int J Oncol 7:1043-1048
4. Cohen JA, Geradts J (1997) Loss of Rb and MTSI/CDKN2 (p16) expression in human sarcomas. Hum Pathol 28:893-898
5. DeiTos AP, Maestro R, Doglioni C, Piccinin S, Libera DD, Boiocchi M, Fletcher CD (1996) Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol 148:1037-1045
6. DeiTos AP, Doglioni C, Piccinin S, Maestro R, Mentzel T, Barbareschi M, Boiocchi M, Fletcher CD (1997a) Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J Pathol 181:8-13
7. DeiTos AP, Piccinin S, Doglioni C, Vukosavljevic T, Mentzel T, Boiocchi M, Fletcher CD (1997b) Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am J Pathol 151:1531-1539
8. Enzinger FM, Weiss SW (1995) Soft tissue tumors. 3rd edn. Mosby, St. Louis Baltimore
9. Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Babin S, Thyss A, Hofman P, Terrier P, Kalifa C, Brunat-Mentigny M, Patricot LM, Oberling F (1996) Loss of heterozygosity of the Rb gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14:467-472
10. Florenes VA, Maelandsmo GM, Forus A, Andreassen A, Mykelbost O, Fodstad O (1994) MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J Natl Cancer Inst 86:1297-1302
11. Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Mykelbost (1993) Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ 4:1065-1070
12. Friend SH, Bernards R, Rogelji S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646
13. Goldmann D, Merril CR (1982) Silver staining of DNA in polyacrylamide gels: linearity and effect of fragment size. Electrophoresis 3:24-26
14. Hall KL, Tenerriello MG, Taylor RR, Lemon S, Ebina M, Linnoila RI, Norris JH, Park RC, Birrer MJ (1997) Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol 65:330-335
15. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H (1997) Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15:2225-2232
16. Ladanyi M, Cha C, Lewis R, Dhanwar SC, Huvos AG, Healey IH (1993) MDM2 amplification in metastatic osteosarcoma. Cancer Res 53:16-18
17. Leach FS, Tokino, T., Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231-2234
18. Meltzer PS (1994) MDM2 and p53: a question of balance. J Natl Cancer Inst 86:1265-1266
19. Mentzel T, Fletcher CDM (1995) Lipomatous tumours of soft tissues: an update. Virchows Arch 427:353-363
20. Miller CW, Also A, Won A, Tan M, Lampkin B, Koeffler HP (1996) Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 122:559-565
21. Momand J, Zambetti GP, Olsom DC, George D, Levine AJ (1992) The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69:1237-1245
22. Mousses S, McAuley L, Bell RS, Kandel R, Andrulis IL (1996) Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod Pathol 9:1-6
23. Nilbert M, Rydholm A, Willen H, Mitelman F, Mandahl N (1994) MDM2 gene amplification correlates with ring chromosome in soft tissue tumors. Genes Chromosomes Cancer 9:261-265
24. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83
25. Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CD, Menzel T, Grimer R, Gusterson BA, Cooper CS (1994) Abnormalities of the p53, MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer 69:1052-1058
26. Pilotti S, Delia Torre G, Lavarino C, DiPalma S, Sozzi G, Minoletti F, Rao S, Pasquini G, Azzarelli A, Rilke F, Pierotti MA (1997) Distinct mdm2 p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 181:14-24
27. Radig K, Schneider-Stock R, Oda Y, Neumann W, Mittler U, Roessner A (1996) Mutation spectrum of p53 gene in highly malignant human osteosarcomas. Gen Diagn Pathol 142:25-32
28. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
29. Schneider-Stock R, Radig K, Oda Y, Mellin W, Rys A, Neizabitowski A, Roessner A (1997a) p53 gene mutations in soft-tissue sarcomas - correlations with p53 immunohistochemistry and DNA ploidy. J Cancer Res Clin Oncol 123:211-218
30. Schneider-Stock R, Haeckel C, Radig K, Pein CD, Roessner A (1997b) Improved detection of p53 mutations in soft tissue tumors using new gel composition for automated nonradioactive analysis of single-strand conformation polymorphism. Electrophoresis 18:2849-2851
31. Schneider-Stock R, Radig K, Roessner A (1997c) Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft-tissue sarcomas. Mol Carcinog 18:63-65
32. Scholz RB, Kabisch H, Weber B, Röser K, Delling G, Winkler K (1992) Studies of the Rb1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol 9:125-137
33. Sreekantaiah C, Ladanyi M, Rodriquez E, Chaganti RSK (1994) Chromosomal aberrations in soft issue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144:1121-1134
34. Stratton MR, Williams S, Fisher C, Ball A, Westbury G, Gusterson BA, Fletcher CD, Knight JC, Fung YK, Reeves BR (1989) Structural alterations of the Rb1 gene in human soft tissue tumors. Br J Cancer 60:202-205
35. Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher CD, Ball A, Thomas M, Gusterson BA (1990) Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the Rb1 gene. Oncogene 5:1297-1301
36. Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H, Rath FW (1995) Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma. Cancer 76:1187-1196
37. Toguchida, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T (1988) Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48:3939-3943
38. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, deMascarel A, Gousssot JF, David M, Bonichon F, Lagarde C (1984) Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37-42
39. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T (1994) Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54:3042-3048
40. Wang J, Coltrera MD, Gown AM (1995) Abnormalities of p53 and p110Rb tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade. Mod Pathol 8:837-842
41. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Blomqvist C, Berner JM, Myklebost O, Knuutila S (1997) Complexity of 12q13 22 amplicon in liposarcoma: microsatellite repeat analysis. Genes Chromosomes Cancer 18:66-70
42. Wunder JS, Czitrom AA, Kandel R, Andrulis IL (1991) Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 83:194-200
43. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers W, Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698
44. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS (1996) Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res. 16, 2009-2015